nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—ABCC2—Spironolactone—dilated cardiomyopathy	0.232	0.42	CbGbCtD
Arsenic trioxide—ABCC2—Furosemide—dilated cardiomyopathy	0.158	0.287	CbGbCtD
Arsenic trioxide—ABCB1—Lisinopril—dilated cardiomyopathy	0.0857	0.156	CbGbCtD
Arsenic trioxide—ABCB1—Spironolactone—dilated cardiomyopathy	0.0755	0.137	CbGbCtD
Arsenic trioxide—CCND1—cardiac ventricle—dilated cardiomyopathy	0.00694	0.0625	CbGeAlD
Arsenic trioxide—CCND1—myocardium—dilated cardiomyopathy	0.00653	0.0587	CbGeAlD
Arsenic trioxide—MAPK1—cardiac ventricle—dilated cardiomyopathy	0.00585	0.0526	CbGeAlD
Arsenic trioxide—MAPK1—myocardium—dilated cardiomyopathy	0.0055	0.0495	CbGeAlD
Arsenic trioxide—TXNRD1—cardiac ventricle—dilated cardiomyopathy	0.00544	0.049	CbGeAlD
Arsenic trioxide—MAPK3—cardiac ventricle—dilated cardiomyopathy	0.00518	0.0466	CbGeAlD
Arsenic trioxide—TXNRD1—myocardium—dilated cardiomyopathy	0.00512	0.0461	CbGeAlD
Arsenic trioxide—AKT1—cardiac ventricle—dilated cardiomyopathy	0.00488	0.0439	CbGeAlD
Arsenic trioxide—MAPK3—myocardium—dilated cardiomyopathy	0.00487	0.0438	CbGeAlD
Arsenic trioxide—AKT1—myocardium—dilated cardiomyopathy	0.00459	0.0413	CbGeAlD
Arsenic trioxide—CCND1—heart—dilated cardiomyopathy	0.00456	0.041	CbGeAlD
Arsenic trioxide—TXNRD1—Testosterone—Spironolactone—dilated cardiomyopathy	0.00433	1	CbGdCrCtD
Arsenic trioxide—JUN—cardiac ventricle—dilated cardiomyopathy	0.00425	0.0382	CbGeAlD
Arsenic trioxide—JUN—myocardium—dilated cardiomyopathy	0.004	0.036	CbGeAlD
Arsenic trioxide—CCND1—cardiac atrium—dilated cardiomyopathy	0.0039	0.0351	CbGeAlD
Arsenic trioxide—MAPK1—heart—dilated cardiomyopathy	0.00384	0.0345	CbGeAlD
Arsenic trioxide—TXNRD1—heart—dilated cardiomyopathy	0.00357	0.0322	CbGeAlD
Arsenic trioxide—MAPK3—heart—dilated cardiomyopathy	0.0034	0.0306	CbGeAlD
Arsenic trioxide—MAPK1—cardiac atrium—dilated cardiomyopathy	0.00328	0.0295	CbGeAlD
Arsenic trioxide—AKT1—heart—dilated cardiomyopathy	0.0032	0.0288	CbGeAlD
Arsenic trioxide—TXNRD1—cardiac atrium—dilated cardiomyopathy	0.00306	0.0275	CbGeAlD
Arsenic trioxide—MAPK3—cardiac atrium—dilated cardiomyopathy	0.00291	0.0262	CbGeAlD
Arsenic trioxide—JUN—heart—dilated cardiomyopathy	0.00279	0.0251	CbGeAlD
Arsenic trioxide—IKBKB—heart—dilated cardiomyopathy	0.00278	0.025	CbGeAlD
Arsenic trioxide—AKT1—cardiac atrium—dilated cardiomyopathy	0.00274	0.0247	CbGeAlD
Arsenic trioxide—JUN—cardiac atrium—dilated cardiomyopathy	0.00239	0.0215	CbGeAlD
Arsenic trioxide—CYP1A1—cardiac ventricle—dilated cardiomyopathy	0.0016	0.0144	CbGeAlD
Arsenic trioxide—CYP1B1—heart—dilated cardiomyopathy	0.00149	0.0134	CbGeAlD
Arsenic trioxide—CYP1A1—heart—dilated cardiomyopathy	0.00105	0.00946	CbGeAlD
Arsenic trioxide—CYP1A1—cardiac atrium—dilated cardiomyopathy	0.000899	0.00809	CbGeAlD
Arsenic trioxide—ABCB1—heart—dilated cardiomyopathy	0.000546	0.00491	CbGeAlD
Arsenic trioxide—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—EGFR—dilated cardiomyopathy	4.25e-05	0.000128	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by FGFR in disease—EGFR—dilated cardiomyopathy	4.24e-05	0.000127	CbGpPWpGaD
Arsenic trioxide—MAPK1—DAP12 interactions—EGFR—dilated cardiomyopathy	4.24e-05	0.000127	CbGpPWpGaD
Arsenic trioxide—MAPK1—Fc epsilon receptor (FCERI) signaling—EGFR—dilated cardiomyopathy	4.24e-05	0.000127	CbGpPWpGaD
Arsenic trioxide—IKBKB—MAPK Signaling Pathway—EGFR—dilated cardiomyopathy	4.23e-05	0.000127	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—RAC1—dilated cardiomyopathy	4.23e-05	0.000127	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by NGF—RAF1—dilated cardiomyopathy	4.22e-05	0.000126	CbGpPWpGaD
Arsenic trioxide—MAPK1—MAPK Signaling Pathway—TNF—dilated cardiomyopathy	4.21e-05	0.000126	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—NPPA—dilated cardiomyopathy	4.21e-05	0.000126	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by EGFR—EGFR—dilated cardiomyopathy	4.21e-05	0.000126	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—PSEN2—dilated cardiomyopathy	4.2e-05	0.000126	CbGpPWpGaD
Arsenic trioxide—MAPK3—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	4.2e-05	0.000126	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—CD36—dilated cardiomyopathy	4.17e-05	0.000125	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by EGFR in Cancer—EGFR—dilated cardiomyopathy	4.17e-05	0.000125	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.15e-05	0.000124	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by PDGF—EGFR—dilated cardiomyopathy	4.15e-05	0.000124	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—ITGB1—dilated cardiomyopathy	4.15e-05	0.000124	CbGpPWpGaD
Arsenic trioxide—AKT1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	4.12e-05	0.000124	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	4.12e-05	0.000123	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	4.11e-05	0.000123	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—RAC1—dilated cardiomyopathy	4.11e-05	0.000123	CbGpPWpGaD
Arsenic trioxide—IKBKB—Cytokine Signaling in Immune system—RAF1—dilated cardiomyopathy	4.1e-05	0.000123	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—RAC1—dilated cardiomyopathy	4.09e-05	0.000123	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	4.08e-05	0.000122	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	4.08e-05	0.000122	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—PSEN2—dilated cardiomyopathy	4.08e-05	0.000122	CbGpPWpGaD
Arsenic trioxide—AKT1—NGF signalling via TRKA from the plasma membrane—EGFR—dilated cardiomyopathy	4.07e-05	0.000122	CbGpPWpGaD
Arsenic trioxide—IKBKB—Fc epsilon receptor (FCERI) signaling—EGFR—dilated cardiomyopathy	4.06e-05	0.000122	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—CD36—dilated cardiomyopathy	4.04e-05	0.000121	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling by NGF—RAF1—dilated cardiomyopathy	4.03e-05	0.000121	CbGpPWpGaD
Arsenic trioxide—IKBKB—MAPK Signaling Pathway—TNF—dilated cardiomyopathy	4.03e-05	0.000121	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—RAC1—dilated cardiomyopathy	4.03e-05	0.000121	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—TAZ—dilated cardiomyopathy	4.02e-05	0.00012	CbGpPWpGaD
Arsenic trioxide—MAPK1—Focal Adhesion—EGFR—dilated cardiomyopathy	4.01e-05	0.00012	CbGpPWpGaD
Arsenic trioxide—MAPK3—Axon guidance—RAF1—dilated cardiomyopathy	4.01e-05	0.00012	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—NPPA—dilated cardiomyopathy	4e-05	0.00012	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—CD36—dilated cardiomyopathy	4e-05	0.00012	CbGpPWpGaD
Arsenic trioxide—MAPK3—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	4e-05	0.00012	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	3.99e-05	0.00012	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	3.99e-05	0.00012	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	3.98e-05	0.000119	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	3.97e-05	0.000119	CbGpPWpGaD
Arsenic trioxide—MAPK3—NGF signalling via TRKA from the plasma membrane—EGFR—dilated cardiomyopathy	3.95e-05	0.000118	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—RAC1—dilated cardiomyopathy	3.93e-05	0.000118	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	3.89e-05	0.000117	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—PSEN2—dilated cardiomyopathy	3.88e-05	0.000116	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	3.86e-05	0.000116	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—CD36—dilated cardiomyopathy	3.85e-05	0.000115	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	3.82e-05	0.000114	CbGpPWpGaD
Arsenic trioxide—MAPK1—Axon guidance—RAF1—dilated cardiomyopathy	3.82e-05	0.000114	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—RAC1—dilated cardiomyopathy	3.81e-05	0.000114	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	3.8e-05	0.000114	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	3.79e-05	0.000114	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—RAC1—dilated cardiomyopathy	3.77e-05	0.000113	CbGpPWpGaD
Arsenic trioxide—MAPK1—NGF signalling via TRKA from the plasma membrane—EGFR—dilated cardiomyopathy	3.76e-05	0.000113	CbGpPWpGaD
Arsenic trioxide—IKBKB—B Cell Activation—EGFR—dilated cardiomyopathy	3.76e-05	0.000113	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	3.75e-05	0.000112	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—CD36—dilated cardiomyopathy	3.68e-05	0.00011	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	3.68e-05	0.00011	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—SDHA—dilated cardiomyopathy	3.63e-05	0.000109	CbGpPWpGaD
Arsenic trioxide—MAPK1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	3.63e-05	0.000109	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—RAC1—dilated cardiomyopathy	3.63e-05	0.000109	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.6e-05	0.000108	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	3.57e-05	0.000107	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	3.55e-05	0.000107	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—CD36—dilated cardiomyopathy	3.54e-05	0.000106	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.51e-05	0.000105	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—RAC1—dilated cardiomyopathy	3.47e-05	0.000104	CbGpPWpGaD
Arsenic trioxide—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	3.41e-05	0.000102	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	3.41e-05	0.000102	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	3.4e-05	0.000102	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—RAC1—dilated cardiomyopathy	3.33e-05	9.99e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	3.3e-05	9.89e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.23e-05	9.67e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—RAC1—dilated cardiomyopathy	3.22e-05	9.66e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	3.21e-05	9.62e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.16e-05	9.46e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	3.14e-05	9.41e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by NGF—EGFR—dilated cardiomyopathy	3.13e-05	9.39e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	3.13e-05	9.38e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—AGT—dilated cardiomyopathy	3.08e-05	9.23e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—PSEN2—dilated cardiomyopathy	3.06e-05	9.18e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by NGF—EGFR—dilated cardiomyopathy	3.04e-05	9.11e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	2.98e-05	8.93e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—ITGB1—dilated cardiomyopathy	2.96e-05	8.89e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—RAF1—dilated cardiomyopathy	2.95e-05	8.85e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.94e-05	8.82e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	2.9e-05	8.7e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—RAF1—dilated cardiomyopathy	2.89e-05	8.68e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by NGF—EGFR—dilated cardiomyopathy	2.89e-05	8.67e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—RAF1—dilated cardiomyopathy	2.86e-05	8.58e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.85e-05	8.56e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—ITGB1—dilated cardiomyopathy	2.85e-05	8.54e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—RAF1—dilated cardiomyopathy	2.81e-05	8.42e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling by NGF—EGFR—dilated cardiomyopathy	2.77e-05	8.29e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—ITGB1—dilated cardiomyopathy	2.76e-05	8.28e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	2.76e-05	8.27e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Axon guidance—EGFR—dilated cardiomyopathy	2.75e-05	8.24e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—RAF1—dilated cardiomyopathy	2.72e-05	8.16e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.72e-05	8.15e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.72e-05	8.15e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.72e-05	8.14e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—RAF1—dilated cardiomyopathy	2.71e-05	8.13e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—RAF1—dilated cardiomyopathy	2.67e-05	8.01e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—AGT—dilated cardiomyopathy	2.64e-05	7.9e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—ITGB1—dilated cardiomyopathy	2.63e-05	7.88e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Axon guidance—EGFR—dilated cardiomyopathy	2.62e-05	7.84e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.61e-05	7.83e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.61e-05	7.83e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—RAF1—dilated cardiomyopathy	2.61e-05	7.81e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—PSEN2—dilated cardiomyopathy	2.6e-05	7.79e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	2.58e-05	7.74e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.53e-05	7.6e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.53e-05	7.6e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.53e-05	7.58e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CD36—dilated cardiomyopathy	2.53e-05	7.58e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—RAF1—dilated cardiomyopathy	2.53e-05	7.58e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—ITGB1—dilated cardiomyopathy	2.51e-05	7.54e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.51e-05	7.51e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—RAF1—dilated cardiomyopathy	2.5e-05	7.5e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.45e-05	7.34e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.43e-05	7.28e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.43e-05	7.28e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CD36—dilated cardiomyopathy	2.43e-05	7.28e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.41e-05	7.23e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.41e-05	7.23e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—RAF1—dilated cardiomyopathy	2.4e-05	7.21e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—AGT—dilated cardiomyopathy	2.39e-05	7.18e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—RAC1—dilated cardiomyopathy	2.38e-05	7.14e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.36e-05	7.06e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CD36—dilated cardiomyopathy	2.36e-05	7.06e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.35e-05	7.05e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—AGT—dilated cardiomyopathy	2.32e-05	6.96e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—RAC1—dilated cardiomyopathy	2.31e-05	6.93e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CXCL2—dilated cardiomyopathy	2.31e-05	6.92e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—AGTR2—dilated cardiomyopathy	2.31e-05	6.92e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—RAF1—dilated cardiomyopathy	2.3e-05	6.9e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—RAC1—dilated cardiomyopathy	2.29e-05	6.86e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.28e-05	6.84e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.24e-05	6.72e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CD36—dilated cardiomyopathy	2.24e-05	6.72e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—RAC1—dilated cardiomyopathy	2.22e-05	6.66e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.22e-05	6.65e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—RAF1—dilated cardiomyopathy	2.21e-05	6.62e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—AGT—dilated cardiomyopathy	2.21e-05	6.62e-05	CbGpPWpGaD
Arsenic trioxide—ABCC2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.18e-05	6.53e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.17e-05	6.51e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.16e-05	6.47e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CXCR3—dilated cardiomyopathy	2.14e-05	6.43e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CD36—dilated cardiomyopathy	2.14e-05	6.43e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.14e-05	6.41e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—RAC1—dilated cardiomyopathy	2.11e-05	6.34e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—RAC1—dilated cardiomyopathy	2.11e-05	6.33e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	2.1e-05	6.31e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.09e-05	6.27e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—ADRB1—dilated cardiomyopathy	2.08e-05	6.23e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—RAC1—dilated cardiomyopathy	2.05e-05	6.14e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—EGFR—dilated cardiomyopathy	2.02e-05	6.07e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—RAC1—dilated cardiomyopathy	2.02e-05	6.06e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.01e-05	6.02e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.98e-05	5.95e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	1.98e-05	5.93e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—EGFR—dilated cardiomyopathy	1.96e-05	5.88e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—RAC1—dilated cardiomyopathy	1.95e-05	5.85e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.95e-05	5.84e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.94e-05	5.83e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—GPX1—dilated cardiomyopathy	1.93e-05	5.78e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—TNF—dilated cardiomyopathy	1.93e-05	5.78e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.91e-05	5.71e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—CD36—dilated cardiomyopathy	1.88e-05	5.63e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—TNF—dilated cardiomyopathy	1.87e-05	5.6e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—EGFR—dilated cardiomyopathy	1.87e-05	5.6e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—EGFR—dilated cardiomyopathy	1.86e-05	5.58e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.85e-05	5.56e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.85e-05	5.54e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	1.79e-05	5.36e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—EGFR—dilated cardiomyopathy	1.79e-05	5.36e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—TNF—dilated cardiomyopathy	1.78e-05	5.33e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—AGTR1—dilated cardiomyopathy	1.77e-05	5.32e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.77e-05	5.3e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.76e-05	5.27e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—EGFR—dilated cardiomyopathy	1.73e-05	5.2e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—EGFR—dilated cardiomyopathy	1.72e-05	5.14e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.7e-05	5.11e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—AGT—dilated cardiomyopathy	1.69e-05	5.07e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	1.69e-05	5.05e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—ADRB2—dilated cardiomyopathy	1.68e-05	5.05e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.66e-05	4.98e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—EGFR—dilated cardiomyopathy	1.65e-05	4.94e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.64e-05	4.91e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.61e-05	4.83e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—GPX1—dilated cardiomyopathy	1.6e-05	4.81e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.59e-05	4.76e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—RAF1—dilated cardiomyopathy	1.58e-05	4.74e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—EGFR—dilated cardiomyopathy	1.58e-05	4.73e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—CD36—dilated cardiomyopathy	1.56e-05	4.68e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—RAC1—dilated cardiomyopathy	1.54e-05	4.62e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—RAF1—dilated cardiomyopathy	1.53e-05	4.6e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—RAF1—dilated cardiomyopathy	1.52e-05	4.55e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—EGFR—dilated cardiomyopathy	1.52e-05	4.54e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.51e-05	4.53e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.48e-05	4.44e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—RAF1—dilated cardiomyopathy	1.47e-05	4.41e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—AGT—dilated cardiomyopathy	1.47e-05	4.41e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.47e-05	4.39e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	1.45e-05	4.34e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—RAC1—dilated cardiomyopathy	1.44e-05	4.3e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—AGT—dilated cardiomyopathy	1.41e-05	4.24e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—AGT—dilated cardiomyopathy	1.41e-05	4.21e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—RAF1—dilated cardiomyopathy	1.4e-05	4.2e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—RAF1—dilated cardiomyopathy	1.4e-05	4.2e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—AGT—dilated cardiomyopathy	1.37e-05	4.11e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—RAC1—dilated cardiomyopathy	1.37e-05	4.09e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—RAF1—dilated cardiomyopathy	1.36e-05	4.07e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—RAF1—dilated cardiomyopathy	1.34e-05	4.02e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—RAC1—dilated cardiomyopathy	1.31e-05	3.92e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—AGT—dilated cardiomyopathy	1.3e-05	3.91e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—RAF1—dilated cardiomyopathy	1.29e-05	3.88e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—AGT—dilated cardiomyopathy	1.25e-05	3.74e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.14e-05	3.41e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.1e-05	3.31e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—EGFR—dilated cardiomyopathy	1.08e-05	3.25e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.05e-05	3.15e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—EGFR—dilated cardiomyopathy	1.04e-05	3.12e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.02e-05	3.07e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—RAF1—dilated cardiomyopathy	1.02e-05	3.06e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—EGFR—dilated cardiomyopathy	1.01e-05	3.03e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—GPX1—dilated cardiomyopathy	9.87e-06	2.96e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—RAF1—dilated cardiomyopathy	9.81e-06	2.94e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CD36—dilated cardiomyopathy	9.61e-06	2.88e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—EGFR—dilated cardiomyopathy	9.61e-06	2.88e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—EGFR—dilated cardiomyopathy	9.6e-06	2.88e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—RAF1—dilated cardiomyopathy	9.52e-06	2.85e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—EGFR—dilated cardiomyopathy	9.32e-06	2.79e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—EGFR—dilated cardiomyopathy	9.19e-06	2.75e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—RAF1—dilated cardiomyopathy	9.06e-06	2.71e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—EGFR—dilated cardiomyopathy	8.87e-06	2.66e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—RAF1—dilated cardiomyopathy	8.66e-06	2.6e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—AGT—dilated cardiomyopathy	8.66e-06	2.6e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	7.88e-06	2.36e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CD36—dilated cardiomyopathy	7.68e-06	2.3e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—EGFR—dilated cardiomyopathy	7e-06	2.1e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—AGT—dilated cardiomyopathy	6.91e-06	2.07e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—EGFR—dilated cardiomyopathy	6.73e-06	2.02e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—EGFR—dilated cardiomyopathy	6.53e-06	1.96e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—EGFR—dilated cardiomyopathy	6.21e-06	1.86e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—EGFR—dilated cardiomyopathy	5.94e-06	1.78e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	4.86e-06	1.46e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	4.73e-06	1.42e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	4.26e-06	1.28e-05	CbGpPWpGaD
